SCHEMBL2014505

SCHEMBL2014505

CN(c1ccc(S(C)(=O)=O)cc1)c1ncnc(NC2CCN(C(=O)O)CC2)c1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 18/20 0.45
PIK3CD O00329 1/20 0.40
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12574266 0.88 GPR119 (0.62) GPR119
SCHEMBL1070010 0.83 GPR119 (0.62) GPR119
SCHEMBL389526 0.76 GPR119 (0.62) GPR119
SCHEMBL12574269 0.75 GPR119 (0.65) GPR119
SCHEMBL305136 0.74 CUL4A (0.45) ALDH1A1
SCHEMBL390473 0.74 GPR119 (0.64) GPR119
SCHEMBL389469 0.72 GPR119 (0.79) GPR119
SCHEMBL20480755 0.71 LMNA (0.39) PIK3CDALDH1A1
SCHEMBL14798234 0.71 LMNA (0.39) PIK3CDALDH1A1
SCHEMBL3681418 0.70 GPR119 (0.65) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110160222-A1 MODULATORS OF GLUCOSE HOMEOSTASIS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS METABOLEX, INC. 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160222-A1 MODULATORS OF GLUCOSE HOMEOSTASIS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS GPR119, GCKR, GID4 GPR119 1/4885PIK3CD 2369/4885ALDH1A1 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.